SMTL ID : 6vng.2 (1 other biounit)

JAK2 JH1 in complex with PN2-118

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x R6M: N-{2-fluoro-5-[(2-{[3-fluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]phenyl}-2-methylpropane-2-sulfonamide(Non-covalent)

R6M.1: 14 residues within 4Å: Chain A: L.31, G.32, G.34, V.39, A.56, M.105, E.106, Y.107, L.108, G.111, D.152, N.157, L.159, D.170 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.31, A:V.39, A:A.56, A:Y.107, A:L.159 Hydrogen bonds: A:L.108, A:L.108

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davis, R.R. et al., Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. J.Med.Chem. (2021)

Release Date

2021-02-17

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence